Health System

Foundation Medicine and Epic struck a deal to integrate comprehensive genomic profiling within Epic's electronic health records (EHRs), allowing for providers to order and review genomic profiling tests, leading to more streamlined clinical decision making.

Delta variant lowers COVID-19 vaccine effectiveness to 66%; Johnson & Johnson reports booster shot results; cancer center reports mask, vaccine preferences of patients.

The European-based survey collected information from over 900 patients and caregivers from 25 countries; the responses show a need for both local and national governments to scale up their services for patients with rare metabolic diseases, which also have a positive spillover effects for caregivers.

Survey responses from patients with advanced cancer revealed that there were gaps in knowledge across various aspects of immunotherapy treatment, including about side effects and curative potential.

Patients with comorbid Alzheimer disease and insomnia were found to be more likely to report claims of higher cost health care services such as inpatient hospitalization and emergency care, along with significantly greater mean total annual health care costs than those without insomnia.

Experts update timetable of COVID-19 vaccine trials for children under 12; vaccine mandates happen nationwide in wake of the Pfizer/BioNTech approval; sedentary behavior is associated with 7-fold increased risk of stroke.

Postoperative management of deep brain stimulation in patients with Parkinson disease was shown to be safe and effective when administered at home, which may reduce necessity of in-clinic visits and care access issues.

COVID-19 booster associated with significantly improved protection against infection in at-risk adults aged 60 and older; spotlighting health risks of climate change for farmworkers; uninsured rate remains stable despite pandemic.

Worsening chronic obstructive pulmonary disease (COPD) symptoms are often underreported by patients who cannot recognize these changes as sign of decline, but they can be objectively measured through remote patient monitoring (RPM).

Findings of the PANORAMA randomized clinical trial show that when patients with severe nonproliferative diabetic retinopathy were treated with intravitreal aflibercept, severity improved over 100 weeks and the likelihood of vision-threatening complications significantly reduced.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A new mathematical model highlights the challenges of preventing Clostridioides difficile transmission in the hospital.

The scientific statement addresses current knowledge regarding the impact of obstructive sleep apnea on the cardiovascular health of children and adolescents, as well as best practices to evaluate symptoms.

Pimavanserin (Nuplazid) initiation among patients with Parkinson disease was associated with greater risk of 30-day hospitalization and mortality up to one year compared with non-users.

Despite executive orders by the Biden administration aimed to improve competition in the pharmaceutical industry, pay-for-delay deals and other antitrust issues continue to be reported. On this episode of Managed Care Cast, we speak on the history and prevalence of these anticompetitive tactics and steps to limit these deals.

US health experts to recommend coronavirus vaccine booster shots for all Americans 8 months after receiving their second dose; 5 states report record 7-day averages of new daily cases of COVID-19; debunking concerns of people receiving blood transfusions from vaccinated individuals.

A recent study found half of hospitalized children received a flu vaccination when their providers used a clinical decision support tool; however, that is still lower than the 63% national average for all children.

The Biden administration announces the largest permanent increase in SNAP benefits history; a potential decision timeline on whether to offer COVID-19 booster shots to Americans may be on the horizon; children hospitalized with COVID-19 reaches a new record high.

Updated evidence provides new insight into safety, efficacy, and challenges of deprescribing.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, speaks on the impact of screen usage for eyes and trends in eye symptom burden reported amid the pandemic.

The meeting comes a day after the FDA approved a third dose of a COVID-19 vaccine from Pfizer-BioNTech and Moderna in people who have received organ transplants or have other conditions that have damaged their immune systems.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Telehealth utilization stabilized in May 2021 after a 3-month drop, according to FAIR Health’s Monthly Telehealth Regional Tracker. Robin Gelburd, JD, president of FAIR Health, discusses the stabilization of telehealth utilization in May 2021 after a 3-month drop.

Fear of negative emotions, lack of interest, and distrust of medical institutions were some of the reasons that participants refused to receive information regarding medically actionable secondary genetic findings, even after they received additional education on what the findings would include.